Aurobindo Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma Limited has announced the results of a Postal Ballot conducted via remote e-voting between February 27, 2026 and March 28, 2026. The special resolution to appoint Dr. (Mrs.) Punita Kumar Sinha (DIN: 05229262) as an Independent Director for a 3-year term (February 9, 2026 to February 8, 2029) was passed with overwhelming shareholder support. Out of 51,34,45,001 valid votes cast, 98.96% (50,81,21,239 votes from 1,266 members) were in favor, while only 1.04% (53,23,762 votes from 113 members) were against. Promoters voted 100% in favor, institutional public shareholders approved at 97.27%, and non-institutional public shareholders approved at 99.93%. The scrutinizer, MRR & Associates, confirmed the resolution was passed with requisite majority.
This is a routine corporate governance event with strong shareholder consensus (98.96% approval). The appointment of an independent director strengthens the board's composition but is unlikely to have any material impact on the stock price or business operations.